- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04138303
Exercise and Nutrition on Obese Microbiome
January 3, 2020 updated by: Wesley Smith, University of Miami
The Effects of a Calorie-Restrictive Low-Carbohydrate Diet Versus an Unrestrictive Ancestral Diet on Microbiota and Cardiometabolic Disease Markers of Obese Individuals Performing an Intense Exercise Program
The purpose of this study is to examine the effects nine weeks of intense exercise training will have on weight, inflammation, and intestinal bacteria composition of overweight and obese adults.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33146
- University of Miami
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria:
- Individuals who are overweight (BMI ≥ 25) and/or obese (BMI ≥ 30).
- Individuals who volunteer for the 54-day exercise program.
- Individuals with no history of diabetes mellitus (type I or II) or sickle cell disease.
- Individuals who are not taking antibiotics and have not taken antibiotics within 3 months.
- Individuals who are not taking probiotics.
- Individuals who are not taking Metformin.
- Individuals who are cleared by their physician to perform strenuous exercise.
- Individuals with no physically debilitating injuries that would keep them from being able to perform the exercises prescribed.
- Individuals who are between 18 and 60.
Exclusion criteria:
1. Any subjects who do not meet all of the inclusion criteria and/or are unable to consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Exercise Only Group (EX)
Participants will only receive the exercise protocol without nutrition education or counseling and instructed to continue to consume their regular diet.
|
The exercise protocol consists of a nine-week progressive intense-conditioning program involving six consecutive days (Monday-Saturday) of one-hour exercises and one-day rest weekly for a total of 54 days of exercise.
Exercises are performed in person as a group with other participating subjects and lead by certified instructors.
Exercises will involve a variety of activities ranging from running, cycling, whole-body functional movements, power movements, and open-chain weight lifting with barbells and resistance bands.
|
Experimental: Exercise with CR-LC Group
Participants will receive the exercise protocol and CR-LC Diet regimen.
|
The exercise protocol consists of a nine-week progressive intense-conditioning program involving six consecutive days (Monday-Saturday) of one-hour exercises and one-day rest weekly for a total of 54 days of exercise.
Exercises are performed in person as a group with other participating subjects and lead by certified instructors.
Exercises will involve a variety of activities ranging from running, cycling, whole-body functional movements, power movements, and open-chain weight lifting with barbells and resistance bands.
Consists of weekly nutrition plans, counseling and monitoring by on-site registered dietitians and nutritionists for nine weeks.
CR-LC consists of caloric and macronutrient restrictions.
Caloric restrictions involves a 40% deficit from calculated total daily energy expenditure.
Macronutrient restriction involves a high protein, low carbohydrate diet (35% protein, 25% carbohydrate and 40% fat).
|
Experimental: Exercise with Ancestral Diet (AD) Group
Participants will receive the exercise protocol and AD regimen.
|
The exercise protocol consists of a nine-week progressive intense-conditioning program involving six consecutive days (Monday-Saturday) of one-hour exercises and one-day rest weekly for a total of 54 days of exercise.
Exercises are performed in person as a group with other participating subjects and lead by certified instructors.
Exercises will involve a variety of activities ranging from running, cycling, whole-body functional movements, power movements, and open-chain weight lifting with barbells and resistance bands.
Consists of weekly nutrition plans, counseling and monitoring by on-site registered dietitians and nutritionists for nine weeks.
AD consists of consuming only whole foods and avoiding processed foods.
Emphasis will be on food quality with no caloric or macronutrient restrictions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in fecal microbiota diversity
Time Frame: Baseline, 9 weeks
|
Change in fecal microbiota alpha-diversity will be assessed via stool sample evaluation
|
Baseline, 9 weeks
|
Change in Bacteriodetes/Firmicutes ratio
Time Frame: Baseline, 9 weeks
|
Change in Bacteriodetes/Firmicutes ratio as assessed via stool sample evaluation
|
Baseline, 9 weeks
|
Percent change in fecal microbiota composition
Time Frame: Baseline, 9 weeks
|
Percent change in Bacteriodetes phyla and percent change of short-chain fatty acid-producing species as assessed via stool sample evaluation
|
Baseline, 9 weeks
|
Change in inflammatory markers
Time Frame: Baseline, 9 weeks
|
Change in serum inflammatory markers including Interleukin (IL)-1ß, IL-6, Tumor Necrosis Factor (TNF)-α and liposaccharide (LPS) evaluated in pg/ml.
|
Baseline, 9 weeks
|
Change in leptin/adiponectin ratio
Time Frame: Baseline, 9 weeks
|
Change in serum adipose markers assessed as change in leptin/adiponectin ratio.
|
Baseline, 9 weeks
|
Correlation of serum triglycerides with leptin levels
Time Frame: Baseline, 9 weeks
|
The correlation of the serum triglyceride levels will be evaluated against serum leptin levels.
|
Baseline, 9 weeks
|
Change in body weight
Time Frame: Baseline, 9 weeks
|
Change in body composition as evaluated as change in body weight measured in lbs.
|
Baseline, 9 weeks
|
Change in resting metabolic rate
Time Frame: Baseline, 9 weeks
|
Change in body composition as evaluated as change in resting metabolic rate measured in Calories per day.
|
Baseline, 9 weeks
|
Change in body composition
Time Frame: Baseline, 9 weeks
|
Change in body composition as evaluated as change in body fat and lean body mass percentage
|
Baseline, 9 weeks
|
Change in waist circumference
Time Frame: Baseline, 9 weeks
|
Change in waist circumference measured in inches.
|
Baseline, 9 weeks
|
Change in blood pressure
Time Frame: Baseline, 9 weeks
|
Change in blood pressure assessed as systolic and diastolic pressure in mmHg.
|
Baseline, 9 weeks
|
Change in visceral fat
Time Frame: Baseline, 9 weeks
|
Change in visceral fat levels will be measured using InBody570 with scores ranging from 1-20, with the higher score indicating increased visceral fat (worse outcome).
|
Baseline, 9 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Wesley Smith, Ph.D., University of Miami
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 21, 2019
Primary Completion (Actual)
December 21, 2019
Study Completion (Actual)
December 21, 2019
Study Registration Dates
First Submitted
October 22, 2019
First Submitted That Met QC Criteria
October 22, 2019
First Posted (Actual)
October 24, 2019
Study Record Updates
Last Update Posted (Actual)
January 7, 2020
Last Update Submitted That Met QC Criteria
January 3, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20190936
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsNot yet recruitingOverweight and Obesity | Overweight, Childhood | Overweight, Infant
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
-
National Taiwan University HospitalCompleted
Clinical Trials on Exercise Protocol
-
Universidade Federal de Sao CarlosRecruiting
-
University of Texas Southwestern Medical CenterWithdrawn
-
Federal University of São PauloUnknownHeart Failure | Physical Activity | Transplant; Failure, HeartBrazil
-
University of ValenciaRecruiting
-
Orthopedic Institute, Sioux Falls, SDCompletedFull Thickness Rotator Cuff TearUnited States
-
Grupo Rehabilitacion en SaludClinica Las AmericasCompletedChronic Heart FailureColombia
-
University of CalgaryHotchkiss Brain Institute, University of CalgaryCompletedBrain Injuries, Traumatic | Post-Concussion Syndrome | Mild Traumatic Brain Injury | Concussion, BrainCanada
-
University of MalagaMinistry of Science, Innovation and Universities, SpainNot yet recruiting
-
Wageningen UniversityGelderse Vallei HospitalUnknownMagnesium Deficiency
-
Boston Medical CenterBrigham and Women's HospitalWithdrawnAdhesive Capsulitis